Literature DB >> 28285075

Thermally triggered hydrogel injection into bovine intervertebral disc tissue explants induces differentiation of mesenchymal stem cells and restores mechanical function.

A A Thorpe1, G Dougill2, L Vickers3, N D Reeves4, C Sammon5, G Cooper6, C L Le Maitre7.   

Abstract

We previously reported a synthetic Laponite® crosslinked pNIPAM-co-DMAc (L-pNIPAM-co-DMAc) hydrogel which promotes differentiation of mesenchymal stem cells (MSCs) to nucleus pulposus (NP) cells without additional growth factors. The clinical success of this hydrogel is dependent on: integration with surrounding tissue; the capacity to restore mechanical function; as well as supporting the viability and differentiation of delivered MSCs. Bovine NP tissue explants were injected with media (control), human MSCs (hMSCs) alone, acellular L-pNIPAM-co-DMAc hydrogel or hMSCs incorporated within the L-pNIPAM-co-DMAc hydrogel and maintained at 5% O2 for 6weeks. Viability of native NP cells and delivered MSCs was maintained. Furthermore hMSCs delivered via the L-pNIPAM-co-DMAc hydrogel differentiated and produced NP matrix components: aggrecan, collagen type II and chondroitin sulphate, with integration of the hydrogel with native NP tissue. In addition L-pNIPAM-co-DMAc hydrogel injected into collagenase digested bovine discs filled micro and macro fissures, were maintained within the disc during loading and restored IVD stiffness. The mechanical support of the L-pNIPAM-co-DMAc hydrogel, to restore disc height, could provide immediate symptomatic pain relief, whilst the delivery of MSCs over time regenerates the NP extracellular matrix; thus the L-pNIPAM-co-DMAc hydrogel could provide a combined cellular and mechanical repair approach. STATEMENT OF SIGNIFICANCE: Low back pain (LBP) is associated with degeneration of the intervertebral disc (IVD). We have previously described development of a jelly delivery system (hydrogel). This has the potential to deliver adult stem cells to the centre of the IVD, known as the nucleus pulposus (NP). Here, we have demonstrated that adult stem cells can be safely injected into the NP using small bore needles, reducing damage to the disc. Following injection the hydrogel integrates with surrounding NP tissue, promotes differentiation of stem cells towards disc cells and restores IVD mechanical function. The hydrogel could be used to restore mechanical function to the IVD and deliver cells to promote regeneration of the disc as a minimally invasive treatment for LBP.
Copyright © 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Injectable hydrogel; Intervertebral disc; Mesenchymal stem cells; Nucleus pulposus; Tissue explant culture

Mesh:

Substances:

Year:  2017        PMID: 28285075     DOI: 10.1016/j.actbio.2017.03.010

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  12 in total

Review 1.  Stem cell therapy in discogenic back pain.

Authors:  Ahmed H Barakat; Vivian A Elwell; Khai S Lam
Journal:  J Spine Surg       Date:  2019-12

2.  A Histopathological Scheme for the Quantitative Scoring of Intervertebral Disc Degeneration and the Therapeutic Utility of Adult Mesenchymal Stem Cells for Intervertebral Disc Regeneration.

Authors:  Cindy C Shu; Margaret M Smith; Susan M Smith; Andrew J Dart; Christopher B Little; James Melrose
Journal:  Int J Mol Sci       Date:  2017-05-12       Impact factor: 5.923

Review 3.  Advancing cell therapies for intervertebral disc regeneration from the lab to the clinic: Recommendations of the ORS spine section.

Authors:  Lachlan J Smith; Lara Silverman; Daisuke Sakai; Christine L Le Maitre; Robert L Mauck; Neil R Malhotra; Jeffrey C Lotz; Conor T Buckley
Journal:  JOR Spine       Date:  2018-10-08

4.  Mesenchymal stem cell therapies for intervertebral disc degeneration: Consideration of the degenerate niche.

Authors:  Louise Vickers; Abbey A Thorpe; Joseph Snuggs; Christopher Sammon; Christine L Le Maitre
Journal:  JOR Spine       Date:  2019-06-26

5.  Leaping the hurdles in developing regenerative treatments for the intervertebral disc from preclinical to clinical.

Authors:  Abbey A Thorpe; Frances C Bach; Marianna A Tryfonidou; Christine L Le Maitre; Fackson Mwale; Ashish D Diwan; Keita Ito
Journal:  JOR Spine       Date:  2018-08-02

Review 6.  Current Progress in the Endogenous Repair of Intervertebral Disk Degeneration Based on Progenitor Cells.

Authors:  Yanbin Zhang; Yiqiang Hu; Wentian Wang; Zijun Guo; Fan Yang; Xianyi Cai; Liming Xiong
Journal:  Front Bioeng Biotechnol       Date:  2021-01-22

7.  Combined Hydrogel and Mesenchymal Stem Cell Therapy for Moderate-Severity Disc Degeneration in Goats.

Authors:  Chenghao Zhang; Sarah E Gullbrand; Thomas P Schaer; Sophie Boorman; Dawn M Elliott; Weiliam Chen; George R Dodge; Robert L Mauck; Neil R Malhotra; Lachlan J Smith
Journal:  Tissue Eng Part A       Date:  2020-08-07       Impact factor: 3.845

Review 8.  Comparison of biomechanical studies of disc repair devices based on a systematic review.

Authors:  Sohrab Virk; Tony Chen; Kathleen N Meyers; Virginie Lafage; Frank Schwab; Suzanne A Maher
Journal:  Spine J       Date:  2020-02-22       Impact factor: 4.297

9.  In vivo safety and efficacy testing of a thermally triggered injectable hydrogel scaffold for bone regeneration and augmentation in a rat model.

Authors:  Abbey A Thorpe; Christine Freeman; Paula Farthing; Jill Callaghan; Paul V Hatton; Ian M Brook; Chris Sammon; Christine Lyn Le Maitre
Journal:  Oncotarget       Date:  2018-04-06

10.  Immunohistochemical analysis of protein expression in formalin fixed paraffin embedded human intervertebral disc tissues.

Authors:  Abbie Binch; Joseph Snuggs; Christine L Le Maitre
Journal:  JOR Spine       Date:  2020-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.